Business

Rectification Report on Decision on Administrative Supervision Measures from Jilin Office of China Securities Regulatory Commission

Rectification Report on Decision on Administrative Supervision Measures from Jilin Office of China Securities Regulatory Commission

articleTonghua Dongbao Pharmaceutical Co., Ltd. Class AFebruary 10, 20264/news/rectification-report-on-decision-on-administrative-supervision-measures-from-jilin-office-of-china-securities-regulatory-commission
Rectification Report on Decision on Administrative Supervision Measures from Jilin Office of China Securities Regulatory Commission

About this update from Tonghua Dongbao Pharmaceutical Co., Ltd. Class A

Rectification Report on Decision on Administrative Supervision Measures from Jilin Office of China Securities Regulatory Commission The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Tonghua Dongbao Pharmaceutical Co., Ltd. Class A